CLINICAL TRIAL: CHILDHOOD ASTHMA MANAGEMENT PROGRAM CONTINUATION STUDY PHASE 2 (

临床试验：儿童哮喘管理计划继续研究第 2 阶段（

• 批准号: 7716563
• 负责人: HAROLD WILLIAM KELLY
• 金额: $ 8.09万
• 依托单位: UNIVERSITY OF NEW MEXICO
• 依托单位国家: 美国
• 财政年份: 2008
• 资助国家: 美国
• 起止时间: 2008-05-01 至 2008-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7716563
• 关键词: Adrenal Cortex Hormones; Adult; Age-Years; Asthma; Breathing; Child; Childhood; Childhood Asthma; Clinical Trials; Computer Retrieval of Information on Scientific Projects Database; Funding; Grant; Growth; Height; Institution; Long-Term Effects; Lung; Phase II Clinical Trials; Purpose; Research; Research Personnel; Resources; Source; Testing; United States National Institutes of Health; cohort; follow-up; programs

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of the study is to further assess the effects of long-term asthma treatment given early in childhood. This study will test whether 3.5 to 5 years of asthma treatment in children 5 to 12 years of age with inhaled corticosteroids has a long-term benefit in allowing maximum attainment of lung growth. This will be achieved by continued follow-up of the original Childhood Asthma Management Program (CAMP) cohort until the majority have reached their maximal adult height.

该子项目是利用该技术的众多研究子项目之一 资源由 NIH/NCRR 资助的中心拨款提供。子项目及 研究者 (PI) 可能已从 NIH 的另一个来源获得主要资金， 因此可以在其他 CRISP 条目中表示。列出的机构是 对于中心来说，它不一定是研究者的机构。 该研究的目的是进一步评估儿童早期长期哮喘治疗的效果。这项研究将测试 5 至 12 岁儿童接受 3.5 至 5 年的哮喘吸入性皮质类固醇治疗是否对实现肺部最大生长有长期益处。 这将通过对最初的儿童哮喘管理计划 (CAMP) 队列的持续随访来实现，直到大多数人达到成年最大身高。